H. Möller

发表

Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin.

A. Frick, H. Möller, E. Wirbitzki, 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Quality Design of Medicinal Products in Light of Current European Community Regulations

H. Möller, 1994 .

MEETING REPORT: Dissolution Testing of Special Dosage Forms

Cynthia K. Brown, V. Shah, H. Möller, 1999 .

Standardized flow-cell method as an alternative to existing pharmacopœial dissolution testing

F. Langenbucher, D. Benz, W. Kürth, 1989 .

Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol.

G L Amidon, D M Barends, M Olling, 2004, Journal of pharmaceutical sciences.

Intermittent maintenance therapy in chronic hand eczema with clobetasol propionate and flupredniden acetate.

G. Dahl, H. Möller, H. Svartholm, 1983, Current medical research and opinion.

Pharmaceutical and biological availability of sustained release preparations of potassium chloride

D. Steinbach, S. L. Ali, H. Möller, 1980 .

Evaluation of pharmaceutical availability from the calculation of drug levels and release profiles

K. Thoma, D. Steinbach, G. Stenzhorn, 1980 .

Lack of clinically important interaction between erythromycin and theophylline

U. Gundert-Remy, E. Weber, R. Hildebrandt, 2004, European Journal of Clinical Pharmacology.

flP Guidelines for Dissolution Testing of Solid Oral Products Joint Report of the Section for O"icial laboratories and Medicines Control Services and the Section of Industrial Pharmacists of the FIP

L. Lesko, V. Shah, J. Dressman, 1997 .

Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system.

H. Möller, E. Wirbitzki, 1993, Bollettino chimico farmaceutico.

Regulatory acceptance of in vitro permeability studies in the context of the biopharmaceutics classification system

Lawrence X. Yu, D. Volpe, H. Möller, 2002 .

The Biopharmaceutical Classification System (BCS) and its usage

Helga Möller, H. Möller, 2002 .

D. Barends, G. Amidon, H. Junginger, 2004, Journal of pharmaceutical sciences.